Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancer.
Murray JL, Macey DJ, Kasi LP, Rieger P, Cunningham J, Bhadkamkar V, Zhang HZ, Schlom J, Rosenblum MG, Podoloff DA.
Murray JL, et al.
Cancer. 1994 Feb 1;73(3 Suppl):1057-66. doi: 10.1002/1097-0142(19940201)73:3+<1057::aid-cncr2820731345>3.0.co;2-3.
Cancer. 1994.
PMID: 8306248
Clinical Trial.